Tag: $Rocket Pharmaceuticals

Rocket Pharmaceuticals shares rise on FDA fast-track designation for heart disease treatment

Shares of Rocket Pharmaceuticals gained 2.3% premarket on Thursday after the late-stage biotech company said the U.S. Food and Drug Administration granted fast-track and orphan-drug designations to its gene therapy candidate for treatment of an inherited heart disease.